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Summary
ICP is a chagasin-family natural tight binding inhibitor
of Clan CA, family C1 cysteine peptidases (CPs). We
investigated the role of ICP in Trypanosoma brucei by
generating bloodstream form ICP-deﬁcient mutants
(Dicp). A threefold increase in CP activity was
detected in lysates of Dicp, which was restored to the
levels in wild type parasites by re-expression of the
gene in the null mutant. Dicp displayed slower growth
in culture and increased resistance to a trypanocidal
synthetic CP inhibitor. More efficient exchange of
the variant surface glycoprotein (VSG) to procyclin
during differentiation from bloodstream to procyclic
form was observed in Dicp, a phenotype that was
reversed in the presence of synthetic CP inhibitors.
Furthermore, we showed that degradation of anti-VSG
IgG is abolished when parasites are pretreated with
synthetic CP inhibitors, and that parasites lacking ICP
degrade IgG more efficiently than wild type. In addi-
tion, Dicp reached higher parasitemia than wild type
parasites in infected mice, suggesting that ICP modu-
lates parasite infectivity. Taken together, these data
suggest that CPs of T. brucei bloodstream form play a
role in surface coat exchange during differentiation,
in the degradation of internalized IgG and in parasite
infectivity, and that their function is regulated by ICP.
Introduction
Clan CA, family C1 cysteine peptidases (CPs) are con-
sidered crucial for the growth, differentiation and survival
of several pathogenic protozoa (for a review, see Sajid
and McKerrow, 2002). In Trypanosoma brucei species,
the pathogenic kinetoplastid protozoa responsible for
human and veterinary trypanosomiasis in sub-Saharan
Africa, the major CP has primary sequence and bio-
chemical characteristics that are broadly similar to those
of mammalian cathepsin L (Lonsdale-Eccles and Grab,
1987; Troeberg et al., 1999; Caffrey et al., 2001), and is
encoded by a tandem array of 11 nearly identical gene
copies (Berriman et al., 2005). The enzymes in T. b.
rhodesiense and T. b. brucei are termed rhodesain and
brucipain (or trypanopain) respectively (Lonsdale-Eccles
and Grab, 1987; Caffrey et al., 2001). It has been dem-
onstrated that small-molecule inhibitors of CPs kill T. b.
brucei in culture as well as in experimentally infected
animals (Scory et al., 1999; Troeberg et al., 1999). Impor-
tantly, killing of the parasites was correlated with inhibition
of brucipain, suggesting that this peptidase plays a crucial
role in the biology of the parasite (Troeberg et al., 1999).
Peptidase activity can be regulated at several levels,
extending from gene expression to the synthesis of inhib-
iting proteins. In mammals and plants, CPs are regulated
by members of the cystatin family (Abrahamson et al.,
2003),whichareabsentfromkinetoplastidprotozoa(Ivens
et al., 2005). A search for endogenous inhibitors of the
parasites CPs resulted in the discovery of a family of
inhibitors distinct from cystatins and other groups of pepti-
dase inhibitors, which were named the chagasin family
(or Inhibitors of Cysteine Peptidases, ICP) (Monteiro et al.,
2001; Sanderson et al., 2003). Chagasin was initially iso-
lated from T. cruzi and is a potent tight-binding inhibitor of
Clan CA, family C1 CPs (Monteiro et al., 2001). Chagasin
homologues were subsequently identiﬁed in other proto-
zoa and in bacteria, and these genes were proven to
encode functional CP inhibitors (Rigden et al. 2002; Sand-
erson et al., 2003; Riekenberg et al., 2005; Pandey et al.,
2006). Structure determination of Leishmania mexicana
ICP and chagasin revealed that they adopt a type of
immunoglobulin (Ig)-like fold not previously reported in
lower eukaryotes (Salmon et al., 2006; Smith et al., 2006;
Figueiredo da Silva et al., 2007). It was demonstrated that,
inT. cruzi,chagasinformstightbindingcomplexeswiththe
major CP of the parasite, cruzipain (Santos et al., 2005).A
fourfoldincreaseininhibitorexpressionintransgenicpara-
sites led to a marked reduction in CP activity, resulting in
reduced differentiation from non-infective epimastigotes to
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thedeleteriouseffectofasyntheticCPinhibitor,anddimin-
ished infectivity of tissue culture trypomastigotes in vitro;
these data suggested that chagasin controls endogenous
CPactivity(Santoset al.,2005).Incontrast,deletionofthe
L. mexicana ICP resulted in reduced infectivity to mice,
although the infection of macrophages in vitro was
unchanged – suggesting that Leishmania ICP might target
the CPs of the host (Besteiro et al., 2004). Recently, it was
shown that Entamoeba histolytica expresses two ICP iso-
types, which display different inhibitory properties against
endogenous CPs and are localized in distinct compart-
ments (Saric et al., 2006; Sato et al., 2006). Similar to the
phenotype observed with T. cruzi, overexpression of
E. histolytica ICPs in trophozoites led to a marked reduc-
tionofCPactivityandofenzymesecretion,suggestingthat
ICPs also regulate endogenous CPs in this parasite
(Sato et al., 2006).
In this study, we investigated the role of ICP in T. brucei
by analysing parasites genetically manipulated to lack ICP.
OurresultssuggestthatT. bruceiICPactsasaregulatorof
endogenous CP activity, and thus plays a part in modula-
tion of surface coat exchange during differentiation, intra-
cellular proteolysis and parasite infectivity to mice.
Results
Targeted deletion of ICP in bloodstream form (BSF)
T. brucei
TargeteddeletionofthediploidT. bruceiICP(TbICP)locus
was achieved by homologous recombination. The two
alleles were sequentially replaced after BSF transfection
with linearized targeting constructs pGL1149 and
pGL1151, containing selectable markers between ICP 5′
and 3′ ﬂanking regions (FRs) (Fig. 1A). For the ﬁrst allele,
transfection with the pGL1151 construct yielded a popula-
tion of parasites resistant to hygromycin. This population
was used for the second round of transfections with the
pGL1149 (blasticidin) construct, and three clones were
obtained. The clones were analysed by Southern blot, one
ofwhichispresented(Fig. 1BandC).TheTbICPgenewas
targeted into the tubulin locus of the Dicp mutants to
generate lines re-expressing ICP (designated Dicp:ICP)
(Fig. 1A, lower panel). A probe to the 5′ FR of TbICP
hybridized with a 3.1 kb SphI/StuI DNA fragment contain-
ing the ICP gene in wild type (WT) parasites, hygromycin-
resistant and blasticidin-resistant heterozygotes, but not in
Dicp (Fig. 1B). Probe hybridization to DNA fragments of
3.5 and 4.2 kb, corresponding to the replacement of ICP
with the blasticidin- or the hygromycin-resistance genes,
was observed in the respective heterozygotes, Dicp and
Dicp:ICP(Fig. 1B).Hybridizationwithaprobetothecoding
region of TbICP revealed the presence of the gene in WT
and in heterozygotes, but not in Dicp (Fig. 1C). As
expected, the TbICP probe hydridized to a 0.8 kb DNA
fragment in the re-expressing cell line, indicating that the
ICPgenewasre-integratedintothetubulinlocus(Fig. 1C).
We were unable to detect ICP expression by Western
blot analysis in WT parasites using a variety of different
antisera raised against recombinant ICP. Thus, the pres-
Fig. 1. Targeted replacement of TbICP.
A. Schematic representation of the TbICP locus and the plasmid
constructs used for gene replacement.
Upper panel: ORFs are shown as arrows; intergenic and ﬂanking
DNA sequences are shown as boxes. The predicted sizes of
StuI/SphI-digested DNA fragments from both native and modiﬁed
TbICP locus are shown.
Lower panel: Schematic representation of the re-integration of ICP
into the tubulin locus of the Dicp line. DHFR, dihydrofolate
reductase gene; BSD, blasticidin-resistance gene; HYG,
hygromycin-resistance gene.
B and C. Southern blot analysis. Genomic DNA was digested with
StuI and SphI, separated on a 0.8% agarose gel, blotted onto a
nylon membrane and hybridized with
32P-labelled DNA probes; 5′
FR of TbICP(B) and TbICP ORF (C). Lane 1, WT T. brucei; lane 2,
BSD-resistant heterozygote; lane 3, HYG-resistant heterozygote;
lane 4, Dicp; lane 5, Dicp:ICP.
992 C. C. Santos, G. H. Coombs, A. P. C. A. Lima and J. C. Mottram
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 66, 991–1002ence of functional ICPin parasite lysates was assessed by
measuringinhibitionofCPactivity.Takingadvantageofthe
fact that ICP is thermostable (Monteiro et al., 2001),
lysates were boiled in order to inactivate endogenous
peptidases prior to incubation with papain. We observed
that boiled lysates of T. cruzi inhibited papain activity more
efficiently than those of WT BSF T. brucei (Fig. 2A). Con-
sidering that recombinant chagasin and ICP inhibit papain
with similar potency (Monteiro et al., 2001; Sanderson
et al., 2003), these results suggest that the levels of ICP in
T. brucei BSF are lower than those of chagasin in T. cruzi.
Low expression levels of ICP in T. brucei BSF could
account for the lack of detection by Western blotting. As
expected, lysates of WT and Dicp:ICP inhibited about 60%
of papain activity, while no inhibitory activity was detected
in Dicp lysates (Fig. 2B), even when tested at 10-fold
higher concentrations (not shown), indicating that func-
tional ICP is absent from Dicp. Lysates from Dicp:ICP
inhibited papain slightly less efficiently than lysates of WT
parasites (Fig. 2B), suggesting that the levels of ICP
expression in the complemented line are not identical to
those in WT parasites. Titration of boiled parasite lysates
against papain revealed that ICP levels in Dicp:ICP are
approximately half of those in WT. We next assessed the
amounts of functional CPs in lysates of BSF by enzymatic
assays using ﬂuorogenic substrates. The CP activity
present in Dicp lysates was threefold higher than in WT or
Dicp:ICP (Fig. 3A).The titration of CPs in the lysates of WT
revealed that the CP : ICP ratio in T. brucei is approxi-
mately 7:1. No alteration in brucipain or cathepsin B-like
CP protein expression by Western blot could be detected
(Fig. 3B and C), indicating that the lack of the ICP did not
induce changes in the expression and/or turnover of these
enzymesandthattheincreaseinCPactivitywasduetothe
absence of ICP.
Deletion of TbICP induces alterations in parasite growth
Growth rate analysis of Dicp in culture indicated that it
grew more slowly than WT or Dicp:ICP over a 5 day period
(Fig. 4A), and this phenotype was reproducible in three
independent Dicp clones. Dicp did not have apparent
Fig. 2. Dicp lacks CP inhibitory activity.
A. T. cruzi epimastigote lysates and T. brucei WT BSF lysates were
boiled and tested (8.5 mg protein ml
-1) for inhibitory CP activity by
pre-incubation with 3 nM papain for 20 min. The residual activity of
the enzyme was measured using 15 mM Z-Phe-Arg-MCA.
B. BSF lysates (50 mg protein) were boiled and tested for the
inhibition of papain by pre-incubating with 2 nM papain for 20 min,
followed by determination of residual peptidase activity using 5 mM
of Z-Phe-Arg-MCA. Asterisk shows scores statistically signiﬁcant
from buffer at P < 0.05.
Fig. 3. CP expression and activity.
A. Five micrograms of BSF lysates was tested for peptidase activity
using 5 mM of Z-Phe-Arg-MCA as a substrate. The activity sensitive
to inhibition by 10 mM of E-64, which corresponds to CP activity, is
shown. The experiments were performed in quadruplicate and are
represented as mean values with standard deviations (SD). The
analysis of signiﬁcance was performed using ANOVA, and the aster-
isk indicates the scores that are statistically signiﬁcantly at P < 0.05.
B and C. Western blot analysis of BSF lysates (equivalent to 5 ¥ 10
5
parasites per lane) using antiserum to (B) brucipain or to (C)
T. brucei cathepsin B. Antibodies to anti-EF1a were used to visualize
loading controls (bottom panels).
Involvement of ICP in T. brucei differentiation 993
© 2007 The Authors
Journal compilation © 2007 Blackwell Publishing Ltd, Molecular Microbiology, 66, 991–1002alterations in morphology or cell cycle progression as
compared with WT, suggesting that the reduced growth
rate might be due to changes in the parasite’s
metabolism.
Wild type and ICP mutant cell lines were inoculated into
Balb/c mice, and parasite density in the blood was exam-
ined from day 3 to day 6 (Fig. 4B). Surprisingly, Dicp
parasites grew better than WT parasites in vivo, reaching
a signiﬁcantly higher parasitemia than the WT or Dicp:ICP
lines. In addition, approximately 50% of the mice infected
with Dicp died at day 7, while the mice infected with WT
survived until day 10 post infection (not shown), indicating
that deﬁciency in ICP increased the parasite’s virulence in
the mammalian host.
Deletion of TbICP increases the resistance to a
synthetic CP inhibitor
Synthetic CP inhibitors have been shown to kill T. brucei
BSF in culture (Troeberg et al., 1999), and their trypano-
cidal effect was associated with the inactivation of the
cathepsin L-like CP of the parasite. Considering that Dicp
parasites have higher CP activity, we decided to test
whether that could have an impact on their sensitivity to
synthetic CP inhibitors. We monitored the densities of
parasite cultures in the presence or absence of the inhibi-
tor at 12, 24 and 30 h. Because Dicp grows slower in vitro,
at the end of this period the culture density of the mutant
line was about half that of WT or Dicp:ICP in the absence
of the drug. However, in the presence of 0.25 mM of N-Pip-
F-hF-VSPh (K11777), the culture densities of the three
lines were nearly identical (~2 ¥ 105 ml-1), suggesting that
the growth of WT and of Dicp:ICP, but not that of Dicp,
were signiﬁcantly affected by K11777. In order to verify
whether Dicp is refractory to the toxic effects of the drug,
we calculated the number of divisions that each line had
undergone in 30 h (Fig. 5). We observed that the growth
of WT parasites was inhibited by 50% in the presence of
0.25 mM of K11777, while it was necessary to increase
drug concentrations 4-fold (to 1 mM) to observe a similar
effect in Dicp parasites. Dicp:ICP had similar drug sensi-
tivity to that of WT parasites, conﬁrming that the increased
resistance displayed by Dicp was due to lack of ICP.
These results show that ICP levels affect BSF sensitivity
to the trypanocidal effect of synthetic CP inhibitors, and
suggest that ICP modulates the availability of active CPs
in the parasite.
Fig. 4. Growth of T. brucei.
A. BSF parasites were seeded at 5 ¥ 10
3 ml
-1 and grown for 5 days
in vitro, with culture density being analysed daily. At the third day, the
cultures were diluted to 5 ¥ 10
3 ml
-1. The mean densities at days 4
(WT: 7 ¥ 10
5 ml





(WT: 9.6 ¥ 10
5 ml
-1; Dicp: 3.5 ¥ 10
5 ml
-1; Dicp:ICP: 8.6 ¥ 10
5 ml
-1)
were multiplied by the respective dilution factors for presentation.
The assay was performed in triplicate and four independent times
(***P < 0.001, in comparison with WT and Dicp:ICP). Keys: closed
square, wild type; open square, Dicp:ICP; triangle, Dicp.
B. BSF parasites were puriﬁed from the blood of infected mice and
injected in Balb/c mice (10
3 parasites per animal). The parasitemia
was determined by counting the number of parasites in 5 ml of blood
from days 3 to 6 of infection. Five mice were used per group, and
the graph is representative of two independent experiments
(***P < 0.001, in comparison with WT and Dicp:ICP). White bars, WT









Fig. 5. Dicp has increased resistance to a CP inhibitor. BSF
parasites were inoculated at 5 ¥ 10
4 ml
-1 in culture medium in the
presence of varying concentrations of K11777, and cultivated for
2 days at 37°C. The controls were cultivated in the presence of
0.5% DMSO. The culture densities were monitored at 12, 24 and
30 h, and the numbers of cell divisions by 30 h are given. The
experiments were performed in triplicate, two independent times,
and are reported as mean and standard deviations of the six
replicates. The analysis of signiﬁcance was performed using
two-way ANOVA and the Bonferroni post-test at a signiﬁcance of
5%. Single asterisks represent scores that are statistically
signiﬁcant at P < 0.05, and triple asterisks show scores statistically
signiﬁcant at P < 0.01. White bars, WT parasites; black bars, Dicp;
grey bars, Dicp:ICP.
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anti-VSG IgG
The surface of BSF T. brucei is covered by a dense coat
of its main surface antigen, the variant surface glycopro-
tein (VSG), which is attached to the membrane via a
glycosylphosphatidylinositol anchor (Ferguson, 1999).
VSGs are encoded by a large family of genes/
pseudogenes sequentially and uniquely expressed at a
given time point, which enables trypanosomes to evade
the host’s immune response (Berriman et al., 2005). VSG
is constitutively removed from the parasite’s surface by
rapid internalization and recycling, a process that medi-
ates the clearance of anti-VSG antibodies from the
surface and might contribute to the parasite’s persistence
in the immune-competent host (Seyfang et al., 1990;
O’Beirne et al., 1998; Gruszynski et al., 2003; 2006;
Engstler et al., 2004). After internalization, VSG is
recycled back to the surface, while the antibodies are de-
graded by intracellular peptidases (O’Beirne et al., 1998;
Pal et al., 2003). To address whether ICP could regulate
the peptidases responsible for IgG processing in BSF, we
assessed the degradation of anti-VSG antibodies follow-
ing internalization (Fig. 6). In WT parasites, an approxi-
mate 50% reduction in the amount of intact IgG was
detected after 20 min of chase, and the protein was sig-
niﬁcantly degraded within 30 min (Fig. 6A, upper panel,
left). In contrast, the amount of elongation factor 1 (EF1),
used as an endogenous control, was unchanged during
the chase, showing that the reduction in IgG was not due
to non-speciﬁc protein degradation during the preparation
of the lysates (Fig. 6, bottom panels). The antibodies were
much more rapidly degraded by Dicp parasites, being
reduced by 80% within the ﬁrst 15 min of chase (Fig. 6B,
upper panel, left), a phenotype that was partially rescued
in Dicp:ICP parasites (Fig. 6C). No difference in the inter-
nalization of transferrin-FITC was observed between the
three lines (data not shown), ruling out that the differences
observed in the amount of IgG detected are due to
alterations in the endocytic activity of the transgenic
parasites. Furthermore, pretreatment of the cells with two
membrane-permeable CP inhibitors, K11777 and E64d,
prevented IgG degradation (Fig. 6A–C, right panels),
demonstrating that CPs are the main peptidases contrib-
uting to IgG degradation in BSF. The results indicate that
the increased IgG degradation by the Dicp parasites was
due to higher CP activity in these parasites, suggesting
that ICP modulates endogenous CP function in BSF
parasites.
Cell surface coat exchange during differentiation from
BSF to procyclic forms (PCF)
One important step in the progression of infection by
T. brucei is the transformation of short stumpy BSF to
Fig. 6. Increased degradation of anti-VSG
IgG by Dicp. BSF parasites were incubated
for 30 min on ice with rabbit anti-VSG 221
IgG, prior to incubation at 37° for 5–30 min to
detect IgG degradation (left panels). Cells
were treated with 20 mM of K11777 (VSPh) or
E64d prior to incubation with IgG and were
chased for 30 min at 37°C (right panels).
Whole-cell lysates were prepared, and
equivalent of 5 ¥ 10
6 cells were loaded in a
SDS-PAGE gel, transferred to nitrocellulose
membranes, followed by incubation with
anti-rabbit IgG HRP conjugate. The
densitometry indicates the ratio of the
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characterized by several metabolic and morphologic
changes, including the expression of cell surface stage-
regulated proteins such as procyclin and the removal of
the old VSG coat. BSF to PCF differentiation can be
induced in vitro by cis-aconitate and low temperature
(Ziegelbauer et al., 1990). Because previous studies have
correlated CP activity with the differentiation of T. cruzi
(Tomás and Kelly, 1996; Santos et al., 2005), we tested
whether deletion of ICP would have an impact on T. brucei
differentiationinvitro.Duringthedifferentiationofsynchro-
nous populations of T. brucei enriched in short stumpy
BSF, the exchange of the VSG coat to procyclin occurs
rapidly and synchronously within 4–24 h (Ziegelbauer
et al., 1993; Van Deursen et al., 2001; Gruszynski et al.,
2003; 2006). However, coat exchange during in vitro dif-
ferentiation of exponentially growing cultures of the 427
strain was shown to occur much slower (24–48 h) and
asynchronously (Roditi et al., 1989; Mutomba and Wang,
1998). We monitored the appearance of cell surface pro-
cyclin and VSG release by ﬂow cytometry in the three
lines during 12–48 h after the induction of differentiation
by cis-aconitate and temperature drop (Fig. 7). We
observed that a higher proportion of the Dicp cell line had
cell surface procyclin by 15 h of differentiation (Fig. 7A
and B) than with WT parasites. The appearance of
procyclin-positive cells correlated with a decrease in the
number of VSG-positive cells (Fig. 7A), and loss of
surface VSG was more rapid in Dicp.After 18 h, about half
of the Dicp population had replaced VSG with procyclin,
while only 20% of WT parasites had exchanged their
surface coat. This phenotype was more evident at 24 h,
when Dicp had nearly completed surface coat exchange
(Fig. 7B), while only half of WT cells were positive for
procyclin in the same time period. The coat exchange of
parasites re-expressing ICP was similar, but not identical,
to that of WT cells, indicating that re-introduction of ICP
partially complemented faster coat exchange of Dicp.
Importantly, the PCF Dicp mutants also grew slower than
WT parasites in vitro, ruling out the possibility that the
higher number of procyclin-positive cells might have
resulted from accelerated growth of the differentiated
Dicp.
It was recently reported that the tyrosine phosphatase
TbPTP1 plays a pivotal role in controlling BSF to PCF
differentiation (Szoor et al., 2006). A cell-permeable
inhibitor of this enzyme, BZ3, induced differentiation of a
small subset of BSF parasites in populations grown in
asynchronous cultures. It was suggested that the cells
sensitive to BZ3-induced differentiation were committed
to early events in stumpy formation before morphological
differentiation occurred, being deﬁned as stumpy*
(Tasker et al., 2000). We treated BSF with BZ3 and
accessed procyclin appearance in early time points
(3–12 h) as a way to assess whether Dicp populations
were enriched in stumpy* forms, thus accounting for the
more efficient coat exchange observed in cis-aconitate-
induced differentiation. The percentage of procyclin-
positive cells was low (< 15%) in the three parasite lines
at 12 h (data not shown). Furthermore, although there
was a small increase in the proportion of procyclin-
positive cells within the Dicp population at 3 h (4% in Dicp
versus 1.5% in WT parasites), all three parasite lines had
equivalent proportions of procyclin-positive cells by 6 h,
indicating that faster coat exchange displayed by Dicp
parasites could not be attributed to a higher proportion of
stumpy* forms prior to triggering of differentiation with
cis-aconitate. Importantly, treatment of parasites with
K11777 during differentiation signiﬁcantly delayed coat
exchange of WT parasites (Fig. 8A and B) and of Dicp
Fig. 7. Differentiation from bloodstream to PCF. BSF were incubated in SDM-79 medium at 27°C, in the presence of 6 mM cis-aconitate and
samples analysed at the indicated times. The exchange of the cell surface coat from VSG (A) to procyclin (B) was quantiﬁed by ﬂow
cytometry and the percentage of ﬂuorescence cells plotted. The experiments were performed in triplicate on three separate occasions. The
graph shows the means plus standard deviations of the nine replicates. The analysis of signiﬁcance was performed using two-way ANOVA and
the Bonferroni post-test at a signiﬁcance of 5%. Single asterisks represent scores that are statistically signiﬁcant at P < 0.05, and double
asterisks represent scores statistically signiﬁcant at P < 0.01). White bars, WT parasites; black bars, Dicp; grey bars, Dicp:ICP.
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the efficiency of coat exchange during T. brucei differen-
tiation. Notably, the effect of the synthetic CP inhibitor in
delaying the coat exchange was detected with WT para-
sites only by 24 h (Fig. 8A and B), while this effect was
observed with Dicp parasites in the ﬁrst 12 h (Fig. 8C and
D). This further suggests that the accelerated coat
exchange in the mutants was associated with increased
CP activity. The parasites remained intact and mobile in
the presence of the inhibitor during the assay, arguing
against non-speciﬁc effects due to toxicity of the drug.
Taken together, these results suggest that ICP plays a
role in controlling the differentiation process through the
modulation of endogenous CP activity.
Discussion
We have used target gene deletion as a strategy to inves-
tigate the function of the chagasin-like CP inhibitor, ICP, in
T. brucei. Deletion of ICP led to increased CP activity in
lysates of BSF parasites, while the expression levels of
brucipain and of the cathepsin B-like peptidase were
unchanged. In WT T. brucei, the CP : ICP ratio calculated
by titration experiments revealed that CPs are in seven-
fold excess, conﬁrming that ICP is expressed at much
lower levels than the CPs. Comparative analyses of
papain inhibition by boiled lysates from different parasite
species indicated that lysates of T. brucei have lower
papain-inhibitory activity than those of T. cruzi. As recom-
binant TbICP is thermo-resistant and displays high affinity
for papain (Sanderson et al., 2003), these observations
suggest that ICP is expressed at low levels in T. brucei
compared with chagasin expression in T. cruzi (Monteiro
et al., 2001; Besteiro et al., 2004; Santos et al., 2005).
Low expression levels might explain why we were unable
to detect ICP in parasite lysates by Western blot. None-
theless, lack of ICP led to a 3- to 4-fold increase in total
CP activity, suggesting that, as observed in T. cruzi and in
Entamoeba, changes in inhibitor expression have a sig-
niﬁcant impact on the overall CP content in parasites
despite the unfavourable inhibitor–enzyme ratio (Santos
et al., 2005; Sato et al., 2006). Because conversion of
zymogens of the CPs to active forms is thought to occur
by auto-catalysis, the rate of CP zymogen processing
and/or sorting could be altered upon ICP deletion, which
could be the explanation for these observations.
Studies with synthetic CP inhibitors have previously
suggested that cathepsin L-like peptidases are the main
targets of these compounds in trypanosomes and in
Leishmania. Our analyses of the effect of K11777 on the
growth of BSF showed that Dicp displays fourfold greater
resistance to this drug than WT parasites, a phenotype
that could be explained by increased availability of free
CPs. The fourfold increase in resistance observed corre-
lates well with the increase in peptidase activity encoun-
tered in the Dicp (3 fold), arguing in favour of the
hypothesis that a higher amount of the synthetic drug is
required to inactivate free CPs in Dicp parasites. Further-
more, it suggests that the availability of active CPs is
subject to endogenous control by ICP. Although the
mechanism by which synthetic CP inhibitors cause
T. brucei death is unknown, in T. cruzi they promote accu-
Fig. 8. Involvement of CPs in the
differentiation from BSF to PCF. Differentiation
of Dicp BSF to PCF in the presence of the
irreversible CP inhibitor K11777 was analysed
as described in Fig. 7.
A and B. WT parasites. White bars, WT
parasites; hatched grey bars, WT parasites +
0.25 mM K11777.
C and D. Dicp. Black bars, Dicp; hatched grey
bars, Dicp + 2 mM K11777.
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of the intracellular traffic and abnormalities in the secre-
tory pathway (Engel et al., 1998). The isolation of resistant
T. cruzi epimastigote populations under selective pres-
sure revealed that upregulation of exocytosis promoted
the secretion of unprocessed CP precursors, sparing the
cells from the deleterious effect of the inhibitor (Engel
et al., 2000). Intriguingly, chagasin overexpression in
T. cruzi also increased parasite resistance to the same
drug (Santos et al., 2005). Although the mechanisms
underlying the increase in resistance are unclear, para-
sites overexpressing chagasin display an increase in
the secretion of CP precursors to the ﬂagellar pocket
(C.C. Santos and A.P.C.A. Lima, unpubl. data), which
mightplaysomepartintheresistance.Theseobservations
suggestthatthebalanceofCPsandendogenousinhibitors
can affect sensitivity to CP inhibitors in multiple ways.
In mammals, T. brucei BSF transform from slender pro-
liferating forms into stumpy non-proliferating forms, which
are competent to differentiate to PCF once ingested by
the tsetse ﬂy (Turner et al., 1995). Our results showed
accelerated coat exchange in conditions of cis-aconitate-
induced differentiation in Dicp, and this phenotype was
reverted in the presence of synthetic CP inhibitors, sug-
gesting that more efficient coat exchange is mediated by
CP activity. Importantly, the use of the tyrosine phos-
phatase inhibitor BZ3 enabled us to verify that the propor-
tion of cells committed to differentiate prior to induction
was similar in the three lines, suggesting that CPs are
fulﬁlling their function at steps subsequent to those that
trigger differentiation. After triggering, BSF-speciﬁc pro-
teins must be degraded (or released) and signiﬁcant
changes in cell shape occur. It is plausible that lysosomal
CPs are required for the massive protein degradation and
remodelling that occurs during differentiation, their activity
being subjected to regulation by ICP.
The inhibition of VSG release during differentiation by
treatment with synthetic CP inhibitors suggests that CPs
play a role in surface coat remodelling either directly or
indirectly, and provides evidence that ICP negatively
modulates endogenous CP activity in BSF. Two main
mechanisms are thought to govern VSG release:
(i) GPI hydrolysis mediated by an endogenous GPI-
phospholipase C (GPI-PLC), responsible for constitutive
shedding in exponentially growing BSF; and (ii) endopro-
teolysis mediated by a zinc metallopeptidase (MSP-B) that
is upregulated during differentiation (Bangs et al., 1997;
Gruszynski et al., 2003; 2006). Proteolytic release of VSG
occurs via truncations upstream of the C-terminal anchor,
but the cleavage sites differ between VSG variants (Bangs
et al., 1997). Endoproteolysis is the main pathway respon-
sible for VSG release during differentiation, and the con-
certed action of both GPI-PLC and MSP-B are thought to
mediate complete shedding of the old VSG coat (Gruszyn-
ski et al., 2006). Despite the fact that inhibitors of metal-
lopeptidases signiﬁcantly block the proteolytic release of
VSG during in vitro differentiation of stumpy BSF, it was
observed that incubation of parasites with the membrane-
permeablesyntheticCPinhibitorMu-F-hF-BzPrresultedin
a small but noticeable reduction of VSG release (Gruszyn-
ski et al., 2003). In addition, a previous independent study
usingthesameCPinhibitorduringdifferentiationofthe427
strainshowedthatVSGwasretainedatthesurfaceofPCF
parasites, suggesting that CPs might play a role in the
release of the VSG coat (Mutomba and Wang, 1998). It is
possible that the relative contribution of CPs to VSG
release varies among different parasite strains.
During T. brucei infections, a robust immune response
is raised against VSG, which is mainly evaded by the
parasite due to VSG antigenic variation. In addition,
in vitro studies have shown that anti-VSG antibodies
bound to the parasite surface are rapidly internalized and
degraded, while VSG remains intact (O’Beirne et al.,
1998).Although it has not yet been demonstrated that IgG
degradation plays a role in immune evasion in vivo,i tw a s
proposed that it could make a contribution to the preven-
tion of antibody-dependent destruction of the parasite.
We observed that treatment of BSF with membrane-
permeable CP inhibitors signiﬁcantly blocked anti-VSG
IgG degradation, indicating that these peptidases play a
central role in IgG degradation. In agreement with this,
Dicp parasites were capable of degrading anti-VSG IgG
with much higher efficiency than WT parasites, provid-
ing additional evidence that ICP negatively controls
CP-mediated intracellular proteolysis in T. brucei. Bruci-
pain is upregulated in stumpy forms (Pamer et al., 1989;
Caffrey et al., 2001), and these forms are more resistant
to antibody-mediated lysis and differentiate more effi-
ciently than monomorphic forms. This is consistent with
our ﬁndings that increased CP activity in BSF promotes
enhanced IgG degradation and cell differentiation.
In BSF, it was shown that degradation of ﬂuorescein-
coupled IgG, measured by changes in ﬂuorescence after
internalization, is abolished when the internal pH of endo-
somal compartments are raised (Pal et al., 2003), sup-
porting the notion that IgG degradation requires the action
of peptidases found in an acidic compartment, such as the
lysosome. The acidic cathepsin L-like CP of T. brucei
(brucipain) is located in the parasite’s lysosome (Caffrey
et al., 2001), and we have previously shown that this
peptidase is the main target of the synthetic inhibitor
K11777 in T. gambiense (Nikolskaia et al., 2006). Consid-
ering that K11777 blocks IgG degradation in T. brucei,i ti s
possible that brucipain, and not the cathepsin B-like pep-
tidase, is the main CP mediating IgG degradation in BSF.
Of note, it was reported that potent inhibitors of brucipain
Z-Phe-Tyr(OtBu)-CHN2 and Z-Phe-Tyr-CHO inhibit lyso-
somal proteolysis of transferrin, further suggesting that
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in BSF (Nkemgu et al., 2003). On the other hand, recent
studies employing RNAi to address the roles of brucipain
and of the cathepsin B-like enzyme in T. brucei suggested
that the latter is responsible for transferrin degradation
(Mackey et al., 2004). In view of these ﬁndings, we pos-
tulate that ICP modulates intracellular proteolysis by
means of inactivating brucipain and the cathepsin B-like
CP in lysosomes. The relative contribution of ICP in
the regulation of each individual CP remains to be
investigated. Although the inhibition of T. brucei CPs by
ICP has not been studied at the biochemical level, it is
known that the affinity of recombinant ICP for human
cathepsin B is approximately 5-fold higher than that for
human cathepsin L (Sanderson et al., 2003). If a similar
inhibition pattern occurs with regards to the parasite CPs,
it is possible that ICP could interact with both CPs of
T. brucei in vivo.
Finally, we observed that lack of ICP enhanced parasite
virulence in vivo, as observed by higher parasitemia in the
blood of infected mice and a more rapid onset of death in
the animals. Although not directly demonstrated, it is very
likely that increased levels of endogenous CPs in the null
mutants are responsible for increased virulence. This
hypothesis is in agreement with several studies showing
that T. brucei CP activity is required for optimal parasite
survival in vitro and in vivo (Troeberg et al., 1999; 2000;
Greenbaum et al., 2004; Fujii et al., 2005; Vicik et al.,
2006). The precise biological processes requiring the
action of CPs for parasite survival are not fully
understood. Even though Dicp is potentially capable of
clearing anti-parasite IgG more efficiently than WT para-
sites, it is unlikely that antibodies play a major role in
eliminating parasites during the early stages (3–6 days) of
infection. Rather, macrophages are thought to play a pro-
tective role during this phase of infection – clearing trypa-
nosomes by phagocytosis and/or by secreting TNF-a and
nitric oxide (NO), which are trypanolytic and trypanostatic
(Magez et al., 1997; Gobert et al., 1998; Tabel et al.,
1999). It has been reported that cruzipain modulates the
activation of murine macrophages, downregulating the
induction of NO synthase and promoting increased sur-
vival of T. cruzi (Stempin et al. 2002). Thus, it is tempting
to speculate that T. brucei CPs also play a role in the
interaction of BSF and macrophages (and/or other cells of
innate immunity), ultimately contributing to increased
parasite numbers during early infection. In addition, we
have recently demonstrated that CPs are directly involved
in the traversal of the blood–brain barrier by T. b.
gambiense, revealing an unexpected role of these
enzymes in brain pathology (Nikolskaia et al., 2006). By
attenuating parasite virulence, ICP expression might be
beneﬁcial for the long-term survival of the parasites in
their natural hosts.
Experimental procedures
Constructs for the deletion of ICP
The 5′ and 3′ FRs of the T. brucei ICP gene (Tb927.8.6450)
were obtained by polymerase chain reaction (PCR) using the
primers OL1609 (CGGCGGCCGCGGTGGAGATTAAAAAAA
GAAAAAAGTG)/OL1610 (CGTCTAGAGCAACAAAAATCA
ATGACATG) and OL1611 (CGGGGCCCGGTATGTGGA
AGTGGAGAAG)/OL1612 (CGGGGCCC GATATCGGCGG
GATGGAGTAAACATA) respectively, with genomic DNA of
T. brucei EATRO795 as the template. The PCR products
were cloned in the TOPO vector for sequencing. The 5′ and
3′ FRs were cloned respectively into the NotI/XbaI and ApaI
sites ﬂanking the blasticidin-resistance gene, generating
vector pGL1149, or into the same sites ﬂanking the
hygromycin-resistance gene, generating vector pGL1151.
For re-expression of the T. brucei ICP gene, the open reading
frame (ORF) was obtained by PCR using the primers NT90/
NT91 (Sanderson et al., 2003) and cloned into the vector
containing a ab-tubulin intergenic region and a phleomycin-
resistance gene (Helms et al., 2006).
Culturing and transfection of parasites
Bloodstream form T. brucei 427 was cultured at 37°C, in a 5%
CO2 humidiﬁed atmosphere, in HMI-9 medium (Hirumi and
Hirumi, 1989) supplemented with 10% (v/v) FCS and 10%
(v/v) serum plus. Twenty micrograms of linearized DNA was
used to transfect 5 ¥ 10
7 mid-log phase parasites in 0.5 ml
ZPFMG (132 mM NaCl, 8 mM Na2HPO4, 1.5 mM KH2PO4,
0.5 mM magnesium acetate, 0.09 mM calcium acetate,
pH 7.0, supplemented with 55 mM glucose, pH 7.0) in a
0.4 cm pulse cuvette set at 1.2 kV, 25 mF, 1 pulse. After
overnight recovery, selection of clones was performed by
limiting dilution with appropriate antibiotics (5 mgm l
-1 blasti-
cidin, 5 mgm l
-1 hygromycin or 2.5 mgm l
-1 phleomycin) in
24-well plates.
Analysis of the transfectants
The genomic DNA from the tranfectants was isolated using
the DNeasy kit (Qiagen) to check for the correct integration of
the constructions. A Southern blot was performed using 3 mg
of gDNA digested with SphI/StuI overnight at 37°C, electro-
phoresed in a 0.8% agarose gel and blotted onto Hybond N
+
membrane (Amersham Pharmacia). The membrane was
blocked with 1 M NaCl/1% SDS/100 mgm l
-1 Salmon DNA
sperm at 65°C for 1 h, and subsequently hybridized with a
779 bp 5′ FR TbICP or 348 bp TbICP as probes, labelled with
the random primer kit (Amersham Pharmacia) overnight at
the same temperature. The membrane was washed three
times with 0.2¥ SSC/0.1% SDS for 15 min and exposed
overnight.
Enzymatic assays
Parasites were washed and resuspended in 50 mM sodium
acetate, 200 mM NaCl, 5 mM EDTA (pH 5.5), 1% NP-40,
incubated on ice for 10 min, followed by centrifugation at
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fraction was determined using the Dc-Protein kit (Bio-Rad).
Samples of 5 mg protein ml
-1 lysates were tested for pepti-
dase activity in 50 mM sodium acetate (pH 5.5), 200 mM
NaCl, 5 mM EDTA, and 5 mM DTT using 5 mM of Z-Phe-Arg-
MCA as substrate. The initial rates were calculated by linear
regression of the substrate hydrolysis curves. The activities
sensitive to inhibition by 10 mM of E64 are shown in Fig. 6.
Because ICP is highly thermo-stable, the detection of inhibi-
tory activity of TbICP was performed after boiling the lysates
(2 mg ml
-1) for 20 min in order to inactivate endogenous CPs,
followed by recovery of the soluble fraction by centrifugation
at 10 000 g for 10 min. The presence of inhibitory activity was
checked by incubation with papain at the concentrations indi-
cated in the legend to Figs 2A and 2B, in 50 mM Na2PO4,
100 mM NaCl, 5 mM EDTA (pH 6.5), and 2.5 mM DTT, for
20 min at room temperature. The remaining activity was mea-
sured by addition of Z-Phe-Arg-MCA at a ﬁnal concentration
o f5o r1 5mM. For the titration of ICP, parasite lysates were
normalized for protein concentration and boiled for 20 min.
The soluble fraction was recovered, and different amounts
(5 independent points) were incubated with 1 nM of papain as
described previously (Monteiro et al., 2001). The residual
enzyme activity was measured by addition of Z-Phe-Arg-
MCA, and the initial velocities were calculated from linear
regression of the substrate hydrolysis plot. The equation of
the linear regression of the V0 (Y) versus lysate concentration
(X) plot was used to calculate the X-value to which Y = 0
(Monteiro et al., 2001).
Analysis of parasite growth in vitro
Bloodstream form WT, Dicp and Dicp:ICP were inoculated
into HMI-9 medium supplemented with 10% (v/v) FCS and
10% (v/v) serum plus at a concentration of 5 ¥ 10
3 cells ml
-1.
The parasites were cultivated for 5 days, with dilution at the
third day to 5 ¥ 10
3 ml
-1, and the growth was estimated by
daily counts of the culture using a haemocytometer chamber.
The culture densities at days 4 and 5 were multiplied by the
day 3 dilution factor before being plotted for the growth curve.
The experiments were performed in triplicate. The analysis of
signiﬁcance was performed by ANOVA using GraphPad Prism
4.0, using the Bonferroni post-test comparing all pairs of
columns at a signiﬁcance of 5%.
Sensitivity to N-Pip-F-hF-VSPh
Bloodstream forms were inoculated at 5 ¥ 10
4 ml
-1 in HMI-9
containing 10% (v/v) FCS and 10% (v/v) serum plus sup-
plemented with 0.5% DMSO or 0.5% DMSO and vari-
able concentrations of the synthetic irreversible cysteine
peptidase inhibitor N-methylpiperazine-urea-phe-homophe-
vinylsulphone-benzene (K11777). The growth was deter-
mined by counting the cell density at 12, 24 and 30 h, using
a Beckman coulter counter. The experiments were performed
in triplicate on three separate occasions. The density of each
culture at 30 h was used to calculate the number of divisions
that had occurred. The IC50 was determined for the three
parasite lines. The analysis of signiﬁcance was performed by
two-way ANOVA using GraphPad Prism 4.0, using the Bonfer-
roni post-test comparing all pairs of columns (all groups to
each other) at a signiﬁcance of 5%.
Anti-VSG 221 IgG degradation
Bloodstream form parasites were harvested at mid-log phase
of growth and labelled with anti-VSG 221 antibodies on ice for
30 min in HMI-9 at a concentration of 1 ¥ 10
7 ml
-1. Parasites
were then washed three times in ice-cold serum-free HMI-9
and incubated at 37°C for 5, 10, 15 or 30 min. Following the
incubation period, samples were prepared for Western blot
analysis. Rabbit anti-VSG IgG was detected directly using an
anti-rabbit IgG-HRP conjugate (Promega) and visualized
by addition of SuperSignal West Pico Chemiluminescence
substrate (Pierce). For the densitometry, the bands were
selected using the Scion Image Program. The intensity of
EF1-awasconsidered100%foreachlane,andtheratioofthe
intensities of IgG and EF1-a was calculated; the densitometry
values are indicated at the bottom of each lane in Fig. 6.
Differentiation to the PCF
Late-log bloodstream forms (8–10 ¥ 10
5 ml
-1) were harvested
and suspended in warm SDM-79 medium containing 10%
(v/v) FCS at a ﬁnal density of 2 ¥ 10
6 ml
-1. Six micromolars of
cis-aconitate (Sigma) was added, and the cultures were incu-
bated at 27°C to allow the differentiation. Aliquots were taken
at different time periods (12, 15, 18, 24, 36 and 48 h), ﬁxed in
2% paraformaldehyde, and analysed for the presence of
VSG or procyclin at the surface by FACS using anti-VSG 221
and anti-procyclin Mab antibodies (Cedarlane Laboratories,
Ontario, Canada), both diluted 1:1000 in PBS containing
1m gm l
-1 BSA, followed by incubation with IgG anti-rabbit or
IgG anti-mouseAlexa 488 secondary antibodies respectively.
The experiments were performed in triplicate on three sepa-
rate occasions. For BZ3 inhibition assays, bloodstream form
parasites were exposed to 150 mM PTP1B inhibitor BZ3
(Calbiochem) in SDM-79 medium containing 10% (v/v) FCS
for 3, 6, 9 or 12 h. The expression of procyclin was assayed
by ﬂow cytometry using anti-procyclin Mab antibody (1:1000).
K11777 was used at the IC50 concentrations for each line.
Mice infections
Cultured bloodstream form parasites (1 ¥ 10
5) were inocu-
lated intraperitoneally in Balb/c mice, harvested from blood
after 5 days of infection, and used to inoculate intraperito-
neally ﬁve mice per group at 1 ¥ 10
3 parasites per animal.
The subsequent parasitemia was determined by counting the
number of parasites in 5 ml of blood samples taken on days
3–6 of infection.
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